Kathryn Martin
Advertisement
Articles by Kathryn Martin
Advertisement
Latest Updated Articles
24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)Published: April 18th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC
2
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
3
Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC
4
Lenvatinib/Everolimus Beats Cabozantinib in Phase 2 RCC Study
5
